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Abstract Cytolytic activity of Met-enke]~halin, an endogenous 
--17 opioid peptide, was studied within the 10- -10 M concentra- 
tion range in K562 human erythroid leukemia cells. Cytolytic 
activity was determined by the trypan blue inclusion method after 
13, 15 and 18 h of Met-enkephalin co-incubation with target 
cells. Discrete maxima of cytolytic activity were detected at 
concentrations of 10-9-10 -1°, 10 -13 and 10 -aS M. Cytolysis was 
accompanied by internucleosomal DNA fragmentation which is 
indicative of the mechanism of cell death being apoptosis. 
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1. Introduction 
More than 200 cells were examined in each well. The experiments 
where percent of dead cells in control wells was more than 15% 
have been excluded. 
2.3. DNA fragmentation assay 
DNA fragmentation was analysed by electrophoresis in 1% agarose 
(Pharmacia) gel as described in [5]. 
K562 cells (106/well) were placed into 24 well plates (Flow) and co- 
incubated with 300 p.1 of serum-free RPMI 1640 medium containing 
different concentrations of Met-enkephalin for 13 h. Untreated cells 
co-incubated with serum-free medium were used as negative control. 
The cells were then treated with lysis buffer (10 mM Tris-HCl, 20 
mM EDTA, 0.2% Triton X-100) and the nuclei and cell debris were 
pelleted. The DNA in the postnuclear supernatant was precipitated by 
isopropanol and separated in 1% agarose gel. DNA fragments were 
stained using ethidium bromide. DNA fragmentation was studied in 
four separate xperiments. 
Morphine has recently been shown to induce apoptosis in 
human lung cancer cells [1], the fact suggesting involvement of 
opioid ligands in signal-induced tumour cell death. A wide 
spectrum of both normal [2] and transformed cells [3] are 
known to bind opioid peptides. In particular, K562 cells 
have been shown to bind enkephalins and to release enzymes 
capable of hydrolysing these peptides [3]. Therefore, we stud- 
ied cytolytic activity of Met-enkephalin, an endogenous ligand 
of the opioid receptor system in K562 tumour cells. 
2. Materials and methods 
2.1. Cell culturing 
K562 (human erythroid leukemia) cells were cultured as described 
in [4]. Briefly, the cells were generated in RPMI 1640 medium en- 
riched with 5% fetal calf serum (Gibco BRL) and supplemented 
with 2 mM of glutamate, 100 U/ml of penicillin and 100 mg/ml of 
streptomycin (Gibco). 
2.2. Cytotoxicity assay 
K562 and L929 cells (5 × 10-4/well) were placed into 94 well plates 
(Flow) and co-incubated with 100 lal of serum-free RPMI 1640 med- 
ium containing different concentrations of Met-enkephalin for 13 h. 
Untreated cells co-incubated with serum-free medium for the same 
time interval were used as negative control. K562 ceils were pelleted 
for 5 min at 300 X g, then 60 pJ of supernatant were removed and the 
remaining cells were stained directly in culture medium. Cytotoxicity 
of the substance Met-enkephalin was determined as the percentage of
trypan blue that stained ceils with damaged plasma membranes, ac- 
cording to Eq. 1: 
Cytotoxicity (%) = ((stained cell number in the sample) : 
(total cell number in the sample)- (stained cell number 
in the negative control) : (total cell number in the 
negative control)) × 100% (1) 
*Corresponding author. 
Abbreviations: TNF, tumour necrosis factor; NT II, neurotoxin II 
from Naja naja oxiana cobra venom 
2.4. Statistical analysis 
Statistical analysis of the data obtained was carried out by Stu- 
dent's t-test. Three parallel wells containing the same concentrations 
of cytolytic substance and three control wells were examined in each 
separate xperiment. The reproducibility of raw data was tested in 11 
separate xperiments. The absolute cytotoxicity values (%) were de- 
termined as stained cell number versus total cell number atio (Eq. 2). 
The reliability (statistical significance) of the differences obtained in 
control and experimental wells was estimated by Student's t-test for 
P < 0.05 and P < 0.01 as described in [6]. 
The cytotoxicity values determined in each experiment were deter- 
mined according to Eq. 1. The mean values, standard deviations 
(S.D.) and coefficient of variation (CV) were determined. CV values 
were determined for each concentration of Met-enkephalin according 
to the formula: [Mean value] : [S.D.] × 100%. The values with CV not 
more than 30% were assumed as reliable according to [6]. 
3. Results and discussion 
The analysis of cytotolytic activity mediated by Met-enke- 
phalin was carried out with K562 human erythroid leukemia 
cell line. The peptide in the 10-7-10 -16 M concentration range 
was incubated with tumor cells for 13 h. The percent of dead 
cells was determined by use of the trypan blue inclusion test 
and compared with negative (untreated cells) control. Under 
these conditions, Met-enkephalin was cytotoxic to K562 cells 
in the 10-7-10 -16 M concentration range. As seen from Fig. 
1, three discrete maxima of cytotoxicity were detected at 
10-9-10 -10, 10 -13 and 10 -15 M concentrations of the peptide. 
As seen from Table 1, statistical evaluation of the data ob- 
tained allowed us to assume the determined cytotoxicity va- 
lues as reliable. 
DNA fragmentation associated with corresponding maxima 
of cytotoxicity was analysed by agarose gel electrophoresis. As 
seen from Fig. 2 Met-enkephalin induces internucleosomal 
DNA fragmentation i  K562 cells at 10 -1° and 10-13-10 -15 
M concentrations corresponding to the maximal values of 
cytolytic activity. One of the most distinguishing features of 
apoptosis is the disintegration of chromatin within the nucleus 
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Fi ,. 1. Cytolytic processes mediated by Met-enkephalin K562 
ce [s at hour 13. 
le, Lding to the formation of 200 bp DNA fragments. As de- 
sc~'ibed by Golstein et al. [7], the presence of internucleosomal 
D XlA fragmentation has been used as a major marker for cell 
death of this type [7,8] and we may thus conclude that Met- 
en kephalin induces the apoptotic mechanism of cell death in 
K ~62 tumor cells. 
Several aspects of the results obtained require further corn- 
mint  and explanation. First, the observed phenomenon is not 
re,~tricted to Met-enkephalin. Similar effects were also exerted 
b.x acetylcholine r ceptor antagonists: neurotoxin II [9], tubo- 
ctrarin [4] and some endogenous cytolytically active sub- 
st, races, including TNF  and substance P [10]. 
The non-saturable character of the cytolytic process was 
al .o observed by means of other methods based on vital dye 
st,dning. In particular, comparable results were obtained for 
F, s-ligand I11] and hepatocyte growth factor [12]. These data 
at,o demonstrate that specifically induced cytolysis may be 
as ~ociated with the development of several complex processes. 
Several explanations for this phenomenon can be suggested. 
F~rst, the asynchronous cell culture contains cells passing si- 
re dtaneously through different stages of the cell cycle. Some 
ol these stages may be more sensitive to cytolytic action whilst 
o1!aers are relatively resistant [13]. Therefore, the interaction 
ol a cytolytic substance with cells differing in their cell cycle 
please may lead to a variety of cytotoxic, cytostatic or prolif- 
er ltive effects [14]. Second, this phenomenon may be also 
ca ased by the involvement of several receptor subtypes asso- 
cL~,ted with different signal transduction systems as suggested 
b.,, Clement and Stamenkovic [11]. In this case, the different 
c( ncentration of cytolytic substance may also induce a variety 
ol effects, including both induction and inhibition of cytolysis. 
TiLird, the target cells of the same culture may also differ in 
th: expression level of intracellular factors involved in regula- 
Fig. 2. DNA fragmentation induced by Met-enkephalin at hour 13. 
~, HindIII standards were used as molecular weight markers. Lanes: 
1, control; 2, 10 -1° M; 3, 10-13; 4, 10-14; 5, 10 15 M Met-enke- 
phalin. 
tion of cell death processes. In this case, the different subpop- 
ulations of target cells may react differently to the same signal. 
At the same time, several factors of this kind may contribute 
simultaneously to developing cytolysis inducing a number of 
cell death patterns. 
The low concentrations of Met-enkephalin required for in- 
duction of cytolysis indicate the high specificity of this effect. 
Met-enkephalin induced apoptosis at concentrations signifi- 
cantly lower than its binding constant (about 10 - l°  M) as 
detected by Scatchard's radio-ligand method [15]. In contrast, 
morphine was cytotoxic in the 10-6-10 -7 M concentration 
range [1]. It was demonstrated earlier that the association of 
radiolabelled Leu-enkephalin with K562 cells was saturable at 
10-14-10 -15 M and that the binding dynamics is quite com- 
plex, suggesting the involvement of several association me- 
chanisms [3]. The kinetic parameters of Leu-enkephalin bind- 
ing correlate closely with the characteristics of Met- 
enkephalin-mediated cytolytic effects as studied on this cell 
line. The highly specific action of the endogenous opioid pep- 
tide, Met-enkephalin, demonstrates the involvement of opioid 
receptors in induction of tumour cell death processes. The 
T;ble 1 
St:ltistical significance and reproducibility of cytotoxicity values represented in Fig. 1 
St ttistical parameters Concentration f Met-enkephalin (M) 
10 7 10-8 10-9 10-10 10 11 10-12 10-13 10-14 10 15 10-16 10-17 
M~'an values 3 6 '~ 13 b 16 b 8 a 6 a 16 b 10 b 20 b 8 a 5 
Standard eviation 1 1 3 2 1 1 3 1 3 1 1 
C\ r (%) 33 17 23 13 13 17 19 10 13 13 20 
Statistical significance of cytotoxicity values is indicated as ap < 0.05 and bp < 0.01. 
232 
presence of more than one process also supports the possibi- 
lity of the involvement of different subtypes of opioid recep- 
tors [16] in cytolysis. Opioid peptides, in particular, Met-en- 
kephalin, were demonstrated to exert growth inhibitory 
activity on various tumour types [17,18]. The presence of 
Met-enkephalin and its precursor, proenkephalin A, was dem- 
onstrated in a wide range of brain tumours. A significant 
inverse correlation between the Met-enkephalin level and de- 
gree of malignancy was found for several tumour types [19]. 
Thus, it may be suggested that the opioid system is involved 
in autocrine inhibition of tumour development. At the same 
time, Met-enkephalin-containing peptides were shown to be 
produced by activated thymocytes and to regulate lymphocyte 
proliferation [20]. It can be proposed that endogenous opioid 
receptor ligands also participate in tumour cell cytolysis 
mediated, in particular, by cytotoxic lymphocytes. 
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